Form D · Biotechnology
Cardio Diagnostics Inc.
Chicago, IL · CIK 0001898439
Offering snapshot reported Oct 5, 2022 · SEC filing
- Reported sold
- $6.49M Offering amount: $6.49M
- Investors reported
- 47 Form D · investor count
- Minimum accepted
- $50K Reported outside-investor minimum
- First sale
- May 23, 2022 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
- Reported investors0 → 47
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Oct 5, 2022 | Amendment | $6,486,036 | No comparison | 47 | SEC filing |
| May 23, 2022 | Amendment | $6,725,000 | $0vs May 17, 2022 | 27 | SEC filing |
| May 19, 2022 | Initial | Yet to sell | No comparison | 0 | SEC filing |
| May 17, 2022 | Amendment | $6,725,000 | $5,675,000vs Dec 17, 2021 | 27 | SEC filing |
| Dec 17, 2021 | Initial | $1,050,000 | No comparison | 15 | SEC filing |
Offering details
- Securities
- Equity, Security to be acquired
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-446282
Sales compensation recipients
Scroll to see all columns →
| Recipient | CRD | Associated broker-dealer |
|---|---|---|
| Emerson Equity LLC | 130032 |
Source: Form D, filed Oct 5, 2022. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Meeshanthini Dogan | Director, Executive |
| Warren Hosseinion | Director |
| Elisa Luqman | Executive |
| Robert Philibert | Director, Executive |
Issuer details
Industry: Biotechnology (See others in industry)
Address:
400 N Aberdeen St. Suite 900
Chicago, IL, 60642
Chicago, IL, 60642